Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
57.8K
-
Shares change
-
+3.56K
-
Total reported value, excl. options
-
$2.12M
-
Value change
-
+$130K
-
Number of buys
-
1
-
Price
-
$36.87
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q4 2023
2 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2023.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.8K shares
of 75.6M outstanding shares and own 0.08% of the company stock.
Largest 10 shareholders include FMR LLC (10.8M shares), VANGUARD GROUP INC (6.04M shares), BlackRock Inc. (5.38M shares), Deep Track Capital, LP (4.06M shares), Boxer Capital, LLC (3.42M shares), ORBIMED ADVISORS LLC (3.22M shares), MARSHALL WACE, LLP (3.02M shares), MAVERICK CAPITAL LTD (2.87M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.78M shares), and STATE STREET CORP (2.62M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.